Answers are grounded in this paper and cite their sources.
Sodium metavanadate (NaVO 3 ) is a pentavalent vanadium compound used in the metal industry and dietary supplements; human exposure occurs through inhalation of fumes and dust and ingestion of NaVO 3 ‐containing products. The objective of this study was to assess the potential immunotoxicity of NaVO 3 . Female B6C3F1/N mice were exposed to 0–500 ppm NaVO 3 in drinking water for 28 days and evaluated for effects on immune cell populations and innate, cellular‐mediated, and humoral‐mediated immunity. There was a decreasing trend in body weight (BW) and BW gain in NaVO 3 exposed mice, with a decrease ( p ≤ 0.05) in BW gain at ≥250 ppm, relative to control. Conversely, increasing trends in spleen weights and an increase ( p ≤ 0.05) in the spleen:BW ratio at ≥250 ppm NaVO 3 were observed. NaVO 3 exposure altered antibody production against sheep red blood cells (SRBC). Antibody forming cells (AFC)/10 6 spleen cells exhibited a decreasing trend, with a decrease ( p ≤ 0.05) at 500 ppm NaVO 3 , concurrent with an increase in percent B cells. NaVO 3 had no effect on the serum anti‐SRBC IgM antibody titers or anti‐keyhole limpet hemocyanin antibody production. Exposure to NaVO 3 decreased the percentage of natural killer cells at all dose levels ( p ≤ 0.05), with no effect on the lytic activity. NaVO 3 altered T‐cell populations at 500 ppm but had no effect on T‐cell proliferative responses or the lytic activity of cytotoxic T cells. Collectively, these data indicate that NaVO 3 exposure can adversely affect the immune system by inducing alterations in humoral‐mediated immunity, specifically the AFC response, with no effect on cell‐mediated or innate immunity.
No takes yet. Share an insight, caveat, or question.
Frawley et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: